Search

everythinglearnresearchcommunity

for

Search:↓

Obesity worsens Polycystic Ovary Syndrome symptoms, and weight loss is a key treatment.

Nanotechnology could make hair loss treatments more effective and reduce side effects, but more research is needed before it's available.

The PCOSQ-50 is a valid and reliable questionnaire for measuring quality of life in Iranian women with PCOS.

Astaxanthin is a safe antioxidant that may improve heart, skin, eye health, and physical performance, and help manage chronic diseases.

Common Black hair care products may affect hormone levels and potentially impact health, especially in reproductive and metabolic areas.

Skin-derived stem cells can become various cell types, including germ cell-like and oocyte-like cells.

The PCOS-specific questionnaire needs more work to fully measure quality of life in clinical trials.

An mFG score of 7 or higher indicates hirsutism in Filipino women, often linked to higher free testosterone levels.

The pituitary gland functions normally even after losing most SOX2+ stem cells.

Chromium supplements don't improve insulin, hormone levels, or cholesterol in women with PCOS but raise testosterone levels.

Obese and non-obese women with PCOS have higher heart risk markers, especially if they are obese.

The Random Forest algorithm was the most accurate at diagnosing Polycystic Ovarian Syndrome.

Women with mild acne are more likely to have polycystic ovary syndrome (PCOS) than those without acne.

Certain changes to the B-ring of androgen receptor ligands can increase their effectiveness for potential treatments of muscle and bone conditions.

High levels of male hormones are very common in women with PCOS and affect their metabolism differently depending on their weight.

Women with PCOS often have more sleep problems than the general population.

The document concludes that diagnosing PCOS in teenagers is difficult and should focus on specific hormone levels and menstrual irregularities, while also considering treatment for symptoms and related health issues.

Eating less starch and dairy helped overweight women with PCOS lose weight and improve symptoms.

Finasteride doesn't change rat testicle weight or sperm production.

Obese women had more testosterone and less acne, but similar hair growth compared to non-obese women.

Women with Polycystic Ovary Syndrome (PCOS) have a lower health-related quality of life, especially those with an anovulatory phenotype, and may need specific interventions to improve it.

The new FDA labeling rules provide more detailed drug safety information for pregnant and breastfeeding women, but more data is needed on the risks of many dermatologic drugs.

The document concludes that more research is needed to fully understand the causes of PCOS.

The document suggests that there might be an autoimmune link between polycystic ovary syndrome and Graves' disease.

CAH is a genetic disorder affecting cortisol production and causing hormonal imbalances, with treatment and diagnosis varying by form and symptoms.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

Finasteride may cause lasting sexual, mental, and physical symptoms; use with caution.

The article concludes that global standardization in PCOS research is crucial for accurate diagnosis and understanding of the condition.

Changing the diagnosis criteria for PCOS might miss women at risk for related health issues.

Laser hair removal is effective for dark hair but needs improvement for nonpigmented or fine hairs.